Skip to main content
. 2025 Jan 1;15(3):993–1016. doi: 10.7150/thno.104872

Figure 3.

Figure 3

Illustration of metformin-based nanomedicines in combination with other therapeutic modalities for reprogramming the tumor microenvironment. Created in https://BioRender.com.